We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Ultrasonic Surgical Platform Integrates Minimally Invasive Therapeutics

By HospiMedica International staff writers
Posted on 20 Jun 2019
A new ultrasonic surgical platform combines cutting, debridement, and aspiration tools into one unified system.

The Misonix (Armingdale, NY, USA) Nexus system is a next-generation integrated ultrasonic surgical platform that combines all the features of the company’s existing solutions into a single system that will also serve to power future solutions. More...
The system includes BoneScalpel, a precision oscillating tool designed for millimeter-wide cuts in bone while sparing surrounding soft tissue; the SonicOne attachment, which provides a debridement tool for cleaning wounds and removing damaged tissue or bacterial biofilms; and the SonaStar ultrasonic aspirator, which removes targeted tissues, such as tumors.

A new proprietary digital algorithm results in more power, efficiency, and control. Physicians can utilize the increased power to improve tissue resection rates, in concert with its proprietary digital algorithm so as to conduct more efficient bone removal procedures. In addition, the system’s a digital touch screen display and smart system setup ensure ease of use, enabling physicians to fully leverage its capabilities. Nexus also incorporates radiofrequency (RF) capabilities, allowing for use in general surgery procedures using proprietary bone-sculpting tips and deep-access and laparoscopic probes.

“Nexus is a powerful, highly integrated, and easy-to-use system that will benefit both healthcare providers and patients by incorporating the latest advances in ultrasonic technology, allowing for increased efficiency and efficacy, and thus improved outcomes,” said Stavros Vizirgianakis, President and CEO of Misonix. “Nexus is a key component of our strategy to increase our presence in the neuro, spine, ortho, wound, and general surgery markets.”

Piezoelectric bone surgery utilizes ultrasonic vibrations to cut hard tissue, while leaving soft tissues untouched by the process. The ultrasonic frequency is modulated to 29 kHz, a low frequency that enables the cutting of the mineralized structures alone. The power is adjusted from 2.8 to 16 W, with preset power settings for various types of bone density. The tip itself vibrates within a range of 60–200 µm, which allows clean cutting with precise incisions.

Related Links:
Misonix


Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Glucose Meter
StatStrip®
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: The findings suggest that hematopoietic cell transplantation may benefit patients with Shwachman-Diamond syndrome soon after high-risk features are detected, before advanced malignancy develops. (Image Credit: Shutterstock)

Early Stem Cell Transplantation May Improve Survival in Rare Inherited Bone Marrow Disorder

Shwachman-Diamond syndrome (SDS) is a rare inherited bone marrow disorder that can progress to severe hematologic disease. More than 90% of affected children survive beyond age 20, but fewer than 30% live... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.